RT @ASCOPost: Nivolumab + Ipilimumab Gets Expanded @US_FDA Approval in Unresectable/Metastatic Melanoma Across BRAF Status https://t.co/56z…
From Twitter for iPhone 11:17am Jan 30 2016 — ¶